Understand the source comparison
LL-37 vs Other Research Peptides: Mechanism Comparison
LL-37 Membrane disruption (bacteria/fungi/viruses) + chemotaxis + cytokine regulation Direct pathogen lysis across Gram+, Gram−, fungi, enveloped viruses Bidirectional. Recruits immune cells at low dose, suppresses hyperinflammation at high dose Epithelial bar
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- LL-37
- Membrane disruption (bacteria/fungi/viruses) + chemotaxis + cytokine regulation
- Direct pathogen lysis across Gram+, Gram−, fungi, enveloped viruses
- Bidirectional. Recruits immune cells at low dose, suppresses hyperinflammation at high dose
- Epithelial barriers, wound beds, mucosal surfaces
- Required when infection risk or immune dysregulation is present. No substitute exists
- BPC-157
- VEGF upregulation + nitric oxide stabilization → angiogenesis
- None
- Indirect anti-inflammatory through reduced oxidative stress
- GI tract, tendons, ligaments
- Accelerates sterile wound healing but cannot address bacterial contamination
- TB-500
- Actin polymerization → cell migration and proliferation
- Indirect. Promotes M2 macrophage phenotype
- Muscle, connective tissue, cardiac
- Excellent for structural repair in clean tissue environments
- Ipamorelin
- Ghrelin receptor agonism → GH pulse → IGF-1 elevation
- Systemic (muscle, adipose, bone)
- Anabolic support only. No pathogen defense
- CJC-1295
- GHRH analog → prolonged GH elevation
- Systemic
- Same anabolic profile as ipamorelin with longer half-life
- AOD-9604
- Lipolysis stimulation via beta-3 adrenergic pathway
- Adipose tissue
- Metabolic focus with zero immune or antimicrobial function